Loss of RUNX3 Immunoreactivity in Non-Neoplastic Rectal Mucosa May Predict the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer
Conclusion: RUNX3 immunostaining of non-neoplastic mucosa is useful for identifying UC patients at a high risk of developing CAC.Digestion
Source: Digestion - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Gastroenterology | Inflammatory Bowel Disease | Ulcerative Colitis